“…The Bonebridge active bone conduction implant (Med-El, Innsbruck, Austria) was developed to overcome the skin- and osteointegration-related complications of bone-anchored hearing aids (BAHAs). Hearing outcomes are comparable between patients with conductive hearing loss who receive the Bonebridge device and those who receive BAHAs [ 1 ]. The Bonebridge device is permitted for use in children over 5 years old in Europe and in those over 12 years old in the United States.…”